| |
Latest 10 SEC filings (by transaction date) for BIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 17/24 | Lakkaraju Roop Kalyan | Direct Ownership | No securities beneficially owned | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 12/24 | Mar 8/24 | Last Andrew J. | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 5,891 | |
Mar 12/24 | Mar 8/24 | May Simon | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Mar 12/24 | Mar 8/24 | Corey Colleen | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,357 | |
Mar 12/24 | Mar 8/24 | Ernst Timothy S | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,357 | |
Mar 12/24 | Mar 8/24 | Evran Sedat | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Mar 12/24 | Mar 8/24 | Schwartz Norman D | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 14,137 | |
Mar 12/24 | Mar 8/24 | Crowley Michael | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Feb 29/24 | Feb 28/24 | Ernst Timothy S | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,500 | |
Feb 29/24 | Feb 28/24 | Ernst Timothy S | Direct Ownership | Bio-Rad A Common Stock | S - Open market or private sale | -2,500 | $330.55 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BIO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 17/24 | Lakkaraju Roop Kalyan | Direct Ownership | No securities beneficially owned | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 12/24 | Mar 8/24 | Last Andrew J. | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 5,891 | |
Mar 12/24 | Mar 8/24 | May Simon | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Mar 12/24 | Mar 8/24 | Corey Colleen | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,357 | |
Mar 12/24 | Mar 8/24 | Ernst Timothy S | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,357 | |
Mar 12/24 | Mar 8/24 | Evran Sedat | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Mar 12/24 | Mar 8/24 | Schwartz Norman D | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 14,137 | |
Mar 12/24 | Mar 8/24 | Crowley Michael | Direct Ownership | Non-Qualified Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 3,535 | |
Feb 29/24 | Feb 28/24 | Ernst Timothy S | Direct Ownership | Non-Qualified Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,500 | |
Feb 29/24 | Feb 28/24 | Ernst Timothy S | Direct Ownership | Bio-Rad A Common Stock | S - Open market or private sale | -2,500 | $330.55 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cencora (N:COR) |
DexCom (OQ:DXCM) |
West Pharmaceutical Servi (N:WST) |